«Radioligand Assay

Below is an extended Radioligand Assay patents listing. Click here to return to the Radioligand Assay main in depth entry.

Patents :
US Patent No.	Title
7053193	Breast cancer transcription factor gene and uses
7160986	BCL-x.gamma., a novel BCL-x isoform, and uses related thereto
7163797	50 human secreted proteins
7164004	Human tumor necrosis factor TR20 and methods based thereon
7164055	HSPC150-like gene disruptions, compositions and methods related thereto
7166449	.alpha.1,3-fucosyltransferase
7172750	Compositions and methods for the treatment and diagnosis of immune disorders
7173108	Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
7176346	SLC19A2 amino acid transporter gene disruptions, and compositions and methods related thereto
7189690	Albumin fusion proteins
7189829	Baboon TAFI polypeptides
7153947	Ixodes salivary anticomplement protein
7144730	Lipoxygenase proteins and polynucleotides encoding the same
7144708	Markers of blood barrier disruption and methods of using same
7071197	N,N-disubstituted diazocycloalkanes
7078487	PTH1R receptors
7078508	Ixodes scapularis tissue factor pathway inhibitor
7091331	Nucleic acid molecules and polypeptides encoding baboon TAFI
7094578	.alpha.1,2 fucosyltransferase
7098233	5-halo-tryptamine derivatives used as ligands on the 5-HT.sub.6 and/or 5-HT.sub.7 serotonin receptors
7112410	Human tumor necrosis factor TR21 and methods based thereon
7115393	Melanocortin-1 receptor and methods of use
7141543	RIEG compositions and therapeutic and diagnostic uses therefor
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7192582	Human monoclonal antibodies to FC alpha receptor (CD89)
7193044	Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7371388	Treatment of Sjogren's syndrome by administration of TR18 polypeptides
7375219	Substituted indole compounds having NOS inhibitory activity
7378504	Human monoclonal antibodies to Fc gamma receptor I (CD64)
7384639	Methods of treating or preventing an infectious disease using an immunogenic conjugate of a gram-negative bacterial autoinducer molecule
7387776	Human monoclonal antibodies against CD30
7387777	Methods of treating hemophilia or von willebrand disease with p-selectin
7408029	Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
7408031	Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
7335637	Biglycan and related therapeutics and methods of use
7303896	Nucleic acid encoding novel type-1 cytokine receptor GLM-R
7297796	Sulfamoyl benzamide derivatives and methods of their use
7202056	Polynucleotides encoding a human cell surface protein with immunoglobulin folds, BGS-19
7217693	Human G protein-coupled receptor expressed in the dorsal root ganglia
7217788	Human tumor necrosis factor delta polypeptides
7238660	Albumin fusion proteins
7238667	Albumin fusion proteins
7238780	G-protein coupled receptor
7247301	Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
7270965	Assays to screen for compounds that bind the dorsal root receptor
7294459	Cell regulatory genes, encoded products, and uses related thereto
7294708	Telomerase reverse transcriptase fragments and uses thereof
7411051	Antibodies to HDPPA04 polypeptide

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.